A new Lancet study forecast what may happen over the next 25 years if more isn't done to address antimicrobial resistant ...

As more drugs approach late-stage development for PAH, Cereno Scientific’s CEO expects more successful disease-modifying ...

Two new drugs, lecanemab and donanemab, have shown the capability of slowing down the debilitating progression of Alzheimer's ...

Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising ...

The union government has banned certain fixed-dose combination drugs due to concerns over safety, efficacy, and potential misuse.

Congressional Republicans are enthusiastically doubling down on the corruption openings five Republicans on the Supreme Court ...

PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.

They walked in with lists of medications and left with boxes – Watch videos and view photos of their operation – The complaints that exposed them ...

BMS is ending its $150m deal with Immatics to help develop its bispecific. Image credit: Getty Images / sesame. Immatics has ...

This Comment is linked to The Lancet Haematology Series on Sexual Health in Patients with Haematological Malignancies; we ...

Pharma's 'blind spot' for Spanish-language TV and Hispanic ... A pair of 30-second TV ads center around a husband and father ...

What trends will dominate the pharma marketing this year ... is what can help increase patient trust and strengthen brand image; all it takes is creating messages that are more personalised ...